A detailed history of Intrua Financial, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Intrua Financial, LLC holds 60,235 shares of PFE stock, worth $1.65 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
60,235
Previous 41,761 44.24%
Holding current value
$1.65 Million
Previous $2.14 Million 14.81%
% of portfolio
0.49%
Previous 0.49%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $727,690 - $947,346
18,474 Added 44.24%
60,235 $2.46 Million
Q4 2022

Jan 20, 2023

BUY
$41.75 - $54.5 $228,497 - $298,278
5,473 Added 15.08%
41,761 $0
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $244,662 - $298,671
-5,591 Reduced 13.35%
36,288 $1.59 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $144,103 - $170,861
3,097 Added 7.99%
41,879 $2.2 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $255,559 - $316,670
5,586 Added 16.83%
38,782 $2.01 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $159,412 - $236,302
-3,858 Reduced 10.41%
33,196 $1.96 Million
Q3 2021

Oct 28, 2021

BUY
$39.25 - $50.42 $521,554 - $669,980
13,288 Added 55.91%
37,054 $1.59 Million
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $19,858 - $22,496
553 Added 2.38%
23,766 $1.1 Million
Q1 2021

Apr 30, 2021

BUY
$33.49 - $37.77 $333,258 - $375,849
9,951 Added 75.03%
23,213 $893,000
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $23,730 - $30,175
709 Added 5.65%
13,262 $488,000
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $172,307 - $202,155
-5,427 Reduced 30.18%
12,553 $485,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $541,557 - $656,989
17,980 New
17,980 $686,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Intrua Financial, LLC Portfolio

Follow Intrua Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrua Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrua Financial, LLC with notifications on news.